Dr. Chanita Hughes-Halbert to Deliver NCI CURE Distinguished Scholars Seminar
September 20, 2018, by CRCHD Staff
CRCHD is pleased to welcome Dr. Chanita Hughes-Halbert as the featured speaker for the next lecture in the NCI’s Continuing Umbrella of Research Experiences (CURE) Distinguished Scholars Seminar series.
Dr. Hughes-Halbert is a Professor in the Department of Psychiatry and Behavioral Sciences and AT&T Distinguished Endowed Chair for Cancer Equity at the Hollings Cancer Center at the Medical University of South Carolina (MUSC). She is also Associate Dean for Assessment, Evaluation, and Quality Improvement in the College of Medicine at MUSC.
A nationally recognized expert in cancer disparities research and behavioral science, Dr. Hughes-Halbert’s research focuses on understanding barriers to clinical trial participation in underserved communities and developing population-based interventions to reduce disparities in local settings. Her interest in minority health and health disparities is very personal for Dr. Hughes-Halbert as she lost both her mother and an aunt to cancer.
Dr. Hughes-Halbert is the recipient of numerous honors and awards, including the American Cancer Society Cancer Control Award, Chair-Elect for the American Association for Cancer Research Minorities in Cancer Research Council, and the MUSC Leadership Fellowship Award. Dr. Hughes-Halbert was the first woman and first African American from South Carolina elected to join the National Academy of Medicine and has authored over 100 peer-reviewed scientific articles.
In her lecture, Translational Issues in Cancer Health Disparities, Dr. Hughes-Halbert will discuss sociocultural, psychological, genetic, and environmental determinants of cancer health disparities and how to translate this information into community interventions to improve cancer outcomes in racially and ethnically diverse populations.
This seminar will take place on Wednesday, October 17, 2018, from 1:00–2:30 PM ET at the Shady Grove campus in TE110. For those unable to attend in person, a webinar option is available. Webinar attendees should click here to register in advance.
The CURE Distinguished Scholars Seminar Series was launched in 2017 as part of the 21 Years of the CURE Program celebration. This semiannual scientific seminar series aims to recognize CURE scholars who have made seminal contributions to the fields of cancer and cancer health disparities research and are role models and mentors for other scientists from backgrounds underrepresented in cancer research.
CRCHD will host distinguished scholar, Dr. Alex A. Adjei, in Spring 2019. Dr. Adjei is a Professor of Oncology and Pharmacology at Mayo Clinic and co-leader of the Early Cancer Therapeutics Program. A former CURE Scholar, Dr. Adjei is a world-renowned clinical scientist with expertise in drug development, cancer pharmacology, early phase clinical trials, and lung cancer, along with a passion for teaching and training the next generation of clinical investigators, particularly underrepresented investigators.
The CURE program supports underrepresented individuals across the academic continuum—beginning in middle school and continuing to cancer research independence—through a pipeline of research funding opportunities.